News stories about Sorrento Tech (NASDAQ:ROKA) have been trending somewhat negative on Tuesday, Accern Sentiment reports. The research group identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Sorrento Tech earned a daily sentiment score of 0.00 on Accern’s scale. Accern also assigned media headlines about the medical research company an impact score of 45.6942797364516 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Here are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:
- Sorrento Tech Inc (ROKA) Is Going Private; Shares Plunge (finance.yahoo.com)
- Sorrento Tech, Inc. Announces Voluntary Delisting from Nasdaq and Closing of … (prnewswire.com)
- Roka Bioscience (ROKA) Announces Voluntary Delisting from Nasdaq (streetinsider.com)
- Sorrento Tech, Inc. Announces Voluntary Delisting from Nasdaq and Closing of its Stock Transfer Books (finance.yahoo.com)
- Sorrento Tech Inc (NASDAQ:ROKA): Should The Recent EPS Drop Worry You? (finance.yahoo.com)
Shares of Sorrento Tech (ROKA) opened at $0.66 on Tuesday. Sorrento Tech has a twelve month low of $0.60 and a twelve month high of $6.20. The firm has a market capitalization of $3.32, a PE ratio of -0.07 and a beta of 2.23.
ILLEGAL ACTIVITY NOTICE: “Sorrento Tech (ROKA) Earning Somewhat Critical News Coverage, Report Finds” was published by Week Herald and is owned by of Week Herald. If you are viewing this news story on another site, it was illegally copied and republished in violation of United States & international trademark & copyright laws. The original version of this news story can be viewed at https://weekherald.com/2017/12/26/sorrento-tech-roka-earning-somewhat-critical-news-coverage-report-finds.html.
About Sorrento Tech
Sorrento Tech, Inc, formerly Roka Bioscience, Inc, is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.
Receive News & Ratings for Sorrento Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Tech and related companies with MarketBeat.com's FREE daily email newsletter.